ARTHEx Biotech to Present Preclinical Data on ATX-01 for Myotonic Dystrophy Type 1 (DM1) at TIDES USA 2023 Meeting ...Middle East

VALENCIA, Spain, May 9, 2023 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, announced today a presentation at the TIDES USA Oligonucleotide & Peptide Therapeutics annual meeting...

Hence then, the article about arthex biotech to present preclinical data on atx 01 for myotonic dystrophy type 1 dm1 at tides usa 2023 meeting was published today ( Tuesday 09/05/2023 - 09:01 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ARTHEx Biotech to Present Preclinical Data on ATX-01 for Myotonic Dystrophy Type 1 (DM1) at TIDES USA 2023 Meeting )

Also on site :

• Country Icon Carrie Underwood’s Latest Career Announcement May Leave Fans Disappointed
• Here's What Airlines Owe You if Your Flight Was Canceled or Delayed During This Weekend's Winter Snowstorm
• Ferry with 342 aboard sinks in the Philippines (VIDEO)